| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |